The synergistic regulatory effect of Runx2 and MEF transcription factors on osteoblast differentiation markers

Journal of Periodontal and Implant Science

Volumn 40, Issue 1, 2010, Pages 39-44

  Lee, Jae Mok ^a   Libermann, Towia A ^b   Cho, Je Yoel ^a  

^a Kyungpook National University   (South Korea)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cell differentiation; Core binding factor alpha 1 subunit; Osteoblasts

Indexed keywords

EID: 84859067316     PISSN: 20932278     EISSN: 20932286     Source Type: Journal    
DOI: 10.5051/jpis.2010.40.1.39     Document Type: Article

References (25)

1. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003;423:337-42.
2. Blair HC, Zaidi M, Schlesinger PH. Mechanisms balanc- ing skeletal matrix synthesis and degradation. Biochem J 2002;364:329-41.
3. Teitelbaum SL. Osteoclasts, integrins, and osteoporosis. J Bone Mineral Metab 2000;18:344-9.
4. Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2002;2: 389-406.
5. Lemaire V, Tobin FL, Greller LD, Cho CR, Suva LJ. Model- ing the interactions between osteoblast and osteoclast ac- tivities in bone remodeling. J Theor Biol 2004;229:293-309
6. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000;289:1504-8.
7. Ducy P, Schinke T, Karsenty G. The osteoblast: a sophisti- cated fibroblast under central surveillance. Science 2000; 289:1501-4.
8. Harada S, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature 2003;423:349-355.
9. Olsen BR, Reginato AM, Wang W. Bone development. Ann Rev Cell Dev Biol 2000;16:191-220.
10. Katagiri T, Takahashi N. Regulatory mechanisms of osteo- blast and osteoclast differentiation. Oral Dis 2002;8:147- 59.
11. Wagner EF, Karsenty G. Genetic control of skeletal devel- opment. Curr Opin Genet Dev 2001;11:527-32.
12. Deng ZL, Sharff KA, Tang N, Song WX, Luo J, Luo X, et al. Regulation of osteogenic differentiation during skeletal Journal of Periodontal JPIS& Implant Science development. Front Biosci 2008;13:2001-21.
13. Raouf A, Seth A. Ets transcription factors and targets in os- teogenesis. Oncogene 2000;19:6455-63.
14. Miyazaki Y, Sun X, Uchida H, Zhang J, Nimer S. MEF, a novel transcription factor with an Elf-1 like DNA binding domain but distinct transcriptional activating properties. Oncogene 1996;13:1721-9.
15. Suico MA, Koyanagi T, Ise S, Lu Z, Hisatsune A, Seki Y, et al. Functional dissection of the ETS transcription factor MEF. Biochim Biophys Acta 2002;1577:113-20.
16. Hedvat CV, Yao J, Sokolic RA, Nimer SD. Myeloid ELF1- like factor is a potent activator of interleukin-8 expression in hematopoietic cells. J Biol Chem 2004;279:6395-400.
17. Lu Z, Kim KA, Suico MA, Shuto T, Li JD, Kai H. MEF up- regulates human beta-defensin 2 expression in epithelial cells. FEBS Lett 2004;561:117-21.
18. Lee MH, Kim YJ, Kim HJ, Park HD, Kang AR, Kyung HM, et al. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteo- blast differentiation by suppression of Dlx5 expression. J Biol Chem 2003;278:34387-94.
19. Harada H, Tagashira S, Fujiwara M, Ogawa S, Katsumata T, Yamaguchi A, et al. Cbfa1 isoforms exert functional dif- ferences in osteoblast differentiation. J Biol Chem 1999; 274:6972-8.
20. Towler DA, Bennett CD, Rodan GA. Activity of the rat os- teocalcin basal promoter in osteoblastic cells is dependent upon homeodomain and CP1 binding motifs. Mol Endo- crinol 1994;8:614-24.
21. Towler DA, Rutledge SJ, Rodan GA. Msx-2/Hox 8.1: a tran- scriptional regulator of the rat osteocalcin promoter. Mol Endocrinol 1994;8:1484-93.
22. Lacorazza HD, Nimer SD. The emerging role of the myel- oid Elf-1 like transcription factor in hematopoiesis. Blood Cells Mol Dis 2003;31:342-50.
23. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, De- guchi K, et al. Targeted disruption of Cbfa1 results in a com- plete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997;89:755-64.
24. Sato M, Morii E, Komori T, Kawahata H, Sugimoto M, Te- rai K, et al. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues. Oncogene 1998;17:1517-25.
25. Wai PY, Mi Z, Gao C, Guo H, Marroquin C, Kuo PC. Ets-1 and runx2 regulate transcription of a metastatic gene, os- teopontin, in murine colorectal cancer cells. J Biol Chem 2006;281:18973-82.